haloperidol and kf 17837s

haloperidol has been researched along with kf 17837s in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F1
Betz, A; Correa, M; Dobson, DR; O'Neill, MF; O'Neill, MJ; Salamone, JD; Wisniecki, A1

Other Studies

2 other study(ies) available for haloperidol and kf 17837s

ArticleYear
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
    European journal of pharmacology, 1994, May-02, Volume: 256, Issue:3

    Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines

1994
The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
    Behavioural brain research, 2004, Jan-05, Volume: 148, Issue:1-2

    Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Inhibition, Psychological; Jaw; Male; Motor Activity; Movement; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tremor; Xanthines

2004